DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,015 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,394 | -1.5% | 45,603 | -1.6% | 1.66% | -2.0% |
| Q1 2024 | $11,568 | +7.0% | 46,325 | -0.8% | 1.69% | +5.3% |
| Q4 2023 | $10,808 | -12.8% | 46,719 | -6.5% | 1.61% | -20.4% |
| Q3 2023 | $12,393 | +1.4% | 49,952 | -1.9% | 2.02% | +5.8% |
| Q2 2023 | $12,219 | +39316.1% | 50,912 | +17639.4% | 1.91% | +38040.0% |
| Q1 2023 | $31 | -99.8% | 287 | -99.5% | 0.01% | -99.8% |
| Q4 2022 | $14,051 | -99.9% | 52,940 | +0.2% | 2.22% | -5.7% |
| Q3 2022 | $13,645,000 | +1.3% | 52,828 | -0.5% | 2.35% | +8.2% |
| Q2 2022 | $13,464,000 | -13.1% | 53,107 | +0.5% | 2.18% | +0.5% |
| Q1 2022 | $15,500,000 | -11.7% | 52,843 | -1.0% | 2.17% | -5.2% |
| Q4 2021 | $17,554,000 | +4.5% | 53,353 | -3.3% | 2.28% | -5.4% |
| Q3 2021 | $16,800,000 | +10.9% | 55,182 | -2.2% | 2.42% | +13.5% |
| Q2 2021 | $15,145,000 | +15.9% | 56,436 | -2.8% | 2.13% | +7.7% |
| Q1 2021 | $13,064,000 | +1.2% | 58,040 | -0.2% | 1.98% | -4.9% |
| Q4 2020 | $12,915,000 | +2.9% | 58,138 | -0.2% | 2.08% | -8.3% |
| Q3 2020 | $12,550,000 | +21.2% | 58,281 | -0.5% | 2.27% | +14.4% |
| Q2 2020 | $10,357,000 | +28.4% | 58,573 | +0.5% | 1.98% | +10.1% |
| Q1 2020 | $8,066,000 | -11.3% | 58,276 | -1.7% | 1.80% | +14.2% |
| Q4 2019 | $9,097,000 | +6.6% | 59,272 | +0.3% | 1.58% | -0.2% |
| Q3 2019 | $8,533,000 | +46.9% | 59,084 | +4.9% | 1.58% | +22.0% |
| Q4 2018 | $5,808,000 | -7.4% | 56,325 | -2.4% | 1.29% | +13.1% |
| Q3 2018 | $6,269,000 | – | 57,700 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |